Cargando…
Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway
BACKGROUND: Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibits its antitumor effects are unknown. Here we aimed to identify the effects and...
Autores principales: | Bai, Xiaoming, Shao, Jiaofang, Zhou, Sujin, Zhao, Zhenggang, Li, Fanghong, Xiang, Rong, Zhao, Allan Z., Pan, Jinshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884860/ https://www.ncbi.nlm.nih.gov/pubmed/31783879 http://dx.doi.org/10.1186/s13046-019-1478-3 |
Ejemplares similares
-
Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner
por: Gao, Jin, et al.
Publicado: (2023) -
Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis
por: Li, Anna, et al.
Publicado: (2020) -
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
por: Fredman, Gabrielle, et al.
Publicado: (2011) -
AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
por: Wang, Ching-Shuen, et al.
Publicado: (2017) -
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
por: Huang, Hui, et al.
Publicado: (2020)